Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as an Adjunct to Fentanyl in Ventilated Neonates
NCT07241351Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- Mar 2024
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dexmedetomidine in pain and agitation, sponsored by Ain Shams University. Primary endpoint: Need for additional rescue analgesia at 24 hours. Started Mar 2024; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
painagitation
Beyond the preview
Go deeper on NCT07241351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07241351.